$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Absence of progesterone receptor membrane component 1 reduces migration and metastasis of breast cancer 원문보기

Cell communication and signaling : CCS, v.19 no.1, 2021년, pp.42 -   

Lee, Sang R. (College of Veterinary Medicine, Chungnam National University, Suite 401, Veterinary Medicine Bldg., 99, Daehak-ro, Yuseong-gu, Daejeon, 34134 Republic of Korea) ,  Lee, Young Ho (College of Veterinary Medicine, Chungnam National University, Suite 401, Veterinary Medicine Bldg., 99, Daehak-ro, Yuseong-gu, Daejeon, 34134 Republic of Korea) ,  Jo, Seong Lae (College of Veterinary Medicine, Chungnam National University, Suite 401, Veterinary Medicine Bldg., 99, Daehak-ro, Yuseong-gu, Daejeon, 34134 Republic of Korea) ,  Heo, Jun H. (College of Veterinary Medicine, Chungnam National University, Suite 401, Veterinary Medicine Bldg., 99, Daehak-ro, Yuseong-gu, Daejeon, 34134 Republic of Korea) ,  Kim, Globinna (Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505 Republic of Korea) ,  Lee, Geun-Shik (College of Veterinary Medicine, Kangwon National University, Chuncheon, 24341 Republic of Korea) ,  An, Beum-Soo (Department of Biomaterials Science, Pusan National University, Miryang, 50463 Republic of) ,  Baek, In-Jeoung ,  Hong, Eui-Ju

Abstract AI-Helper 아이콘AI-Helper

BackgroundProgesterone receptor membrane component 1 (Pgrmc1) is a non-classical progesterone receptor associated with the development of the mammary gland and xenograft-induced breast cancer. Importantly, Pgrmc1 is associated with the expression of estrogen receptor alpha and can be used for predic...

Keyword

참고문헌 (34)

  1. 1. Momenimovahed Z Salehiniya H Epidemiological characteristics of and risk factors for breast cancer in the world Breast Cancer (Dove Med Press) 2019 11 151 164 31040712 

  2. 2. Jin L Han B Siegel E Cui Y Giuliano A Cui X Breast cancer lung metastasis: molecular biology and therapeutic implications Cancer Biol Ther 2018 19 858 868 10.1080/15384047.2018.1456599 29580128 

  3. 3. Zeisberg M Neilson EG Biomarkers for epithelial–mesenchymal transitions J Clin Invest 2009 119 1429 1437 10.1172/JCI36183 19487819 

  4. 4. Gennari A Conte P Rosso R Orlandini C Bruzzi P Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies Cancer 2005 104 1742 1750 10.1002/cncr.21359 16149088 

  5. 5. Valastyan S Weinberg RA Tumor metastasis: molecular insights and evolving paradigms Cell 2011 147 275 292 10.1016/j.cell.2011.09.024 22000009 

  6. 6. Donegan WL Tumor-related prognostic factors for breast cancer CA Cancer J Clin 1997 47 28 51 10.3322/canjclin.47.1.28 8996077 

  7. 7. Lower EE Glass EL Bradley DA Blau R Heffelfinger S Impact of metastatic estrogen receptor and progesterone receptor status on survival Breast Cancer Res Treat 2005 90 65 70 10.1007/s10549-004-2756-z 15770528 

  8. 8. Rohe HJ Ahmed IS Twist KE Craven RJ PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding Pharmacol Ther 2009 121 14 19 10.1016/j.pharmthera.2008.09.006 18992768 

  9. 9. Lee SR Choi WY Heo JH Huh J Kim G Lee KP Kwun HJ Shin HJ Baek IJ Hong EJ Progesterone increases blood glucose via hepatic progesterone receptor membrane component 1 under limited or impaired action of insulin Sci Rep 2020 10 16316 10.1038/s41598-020-73330-7 33005004 

  10. 10. Kim G, Lee JG, Cheong SA, Yon JM, Lee MS, Hong EJ, Baek IJ. Progesterone receptor membrane component 1 is required for mammary gland development. Biol Reprod. 2020. 

  11. 11. Zhang Y Ruan X Willibald M Seeger H Fehm T Neubauer H Mueck AO May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer? Gynecol Endocrinol 2016 32 58 60 10.3109/09513590.2015.1078303 26303031 

  12. 12. Asperger H Stamm N Gierke B Pawlak M Hofmann U Zanger UM Marton A Katona RL Buhala A Vizler C Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression Breast Cancer Res 2020 22 75 10.1186/s13058-020-01312-8 32660617 

  13. 13. Pedroza DA, Rajamanickam V, Subramani R, Bencomo A, Galvez A, Lakshmanaswamy R. Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling. Br J Cancer. 2020. 

  14. 14. Guy CT Cardiff RD Muller WJ Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease Mol Cell Biol 1992 12 954 961 10.1128/MCB.12.3.954 1312220 

  15. 15. Na TY Schecterson L Mendonsa AM Gumbiner BM The functional activity of E-cadherin controls tumor cell metastasis at multiple steps Proc Natl Acad Sci USA 2020 117 5931 5937 10.1073/pnas.1918167117 32127478 

  16. 16. Lee SR Kwon SW Kaya P Lee YH Lee JG Kim G Lee GS Baek IJ Hong EJ Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis Sci Rep 2018 8 15711 10.1038/s41598-018-34148-6 30356113 

  17. 17. Huang HY, Chou HC, Law CH, Chang WT, Wen TN, Liao EC, Lin MW, Lin LH, Wei YS, Tsai YT, et al. Progesterone receptor membrane component 1 is involved in oral cancer cell metastasis. J Cell Mol Med. 2020. 

  18. 18. Ahmed IS Rohe HJ Twist KE Mattingly MN Craven RJ Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule J Pharmacol Exp Ther 2010 333 564 573 10.1124/jpet.109.164210 20164297 

  19. 19. Huang HY Chou HC Law CH Chang WT Wen TN Liao EC Lin MW Lin LH Wei YS Tsai YT Progesterone receptor membrane component 1 is involved in oral cancer cell metastasis J Cell Mol Med 2020 24 9737 9751 10.1111/jcmm.15535 32672400 

  20. 20. Ponikwicka-Tyszko D Chrusciel M Stelmaszewska J Bernaczyk P Chrusciel P Sztachelska M Scheinin M Bidzinski M Szamatowicz J Huhtaniemi IT Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression EBioMedicine 2019 47 170 183 10.1016/j.ebiom.2019.08.035 31466918 

  21. 21. Shih CC Chou HC Chen YJ Kuo WH Chan CH Lin YC Liao EC Chang SJ Chan HL Role of PGRMC1 in cell physiology of cervical cancer Life Sci 2019 231 116541 10.1016/j.lfs.2019.06.016 31216441 

  22. 22. Clark NC Friel AM Pru CA Zhang L Shioda T Rueda BR Peluso JJ Pru JK Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors Cancer Biol Ther 2016 17 262 271 10.1080/15384047.2016.1139240 26785864 

  23. 23. Lobbezoo DJ van Kampen RJ Voogd AC Dercksen MW van den Berkmortel F Smilde TJ van de Wouw AJ Peters FP van Riel JM Peters NA Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer 2015 112 1445 1451 10.1038/bjc.2015.127 25880008 

  24. 24. Caswell-Jin JL Plevritis SK Tian L Cadham CJ Xu C Stout NK Sledge GW Mandelblatt JS Kurian AW Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review JNCI Cancer Spectr 2018 2 pky062 10.1093/jncics/pky062 30627694 

  25. 25. Rivera E Gomez H Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone Breast Cancer Res 2010 12 Suppl 2 S2 10.1186/bcr2573 

  26. 26. Cai G Yang X Ruan X Wang J Fang Y Wei Y Zhang Y Gu M Mueck AO Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics Maturitas 2020 140 64 71 10.1016/j.maturitas.2020.06.008 32972637 

  27. 27. Chan KT Cortesio CL Huttenlocher A FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion J Cell Biol 2009 185 357 370 10.1083/jcb.200809110 19364917 

  28. 28. Sabbir MG Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1 J Steroid Biochem Mol Biol 2019 191 105376 10.1016/j.jsbmb.2019.105376 31067491 

  29. 29. Thejer BM Adhikary PP Kaur A Teakel SL Van Oosterum A Seth I Pajic M Hannan KM Pavy M Poh P PGRMC1 phosphorylation affects cell shape, motility, glycolysis, mitochondrial form and function, and tumor growth BMC Mol Cell Biol 2020 21 24 10.1186/s12860-020-00256-3 32245408 

  30. 30. Lahlou H Sanguin-Gendreau V Zuo D Cardiff RD McLean GW Frame MC Muller WJ Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression Proc Natl Acad Sci USA 2007 104 20302 20307 10.1073/pnas.0710091104 18056629 

  31. 31. Owyong M, Chou J, van den Bijgaart RJ, Kong N, Efe G, Maynard C, Talmi-Frank D, Solomonov I, Koopman C, Hadler-Olsen E, et al. MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy. Life Sci Alliance. 2019;2. 

  32. 32. Kim D Rhee S Matrix metalloproteinase2 regulates MDAMB231 breast cancer cell invasion induced by active mammalian diaphanous-related formin 1 Mol Med Rep 2016 14 277 282 10.3892/mmr.2016.5282 27177153 

  33. 33. Mir SU Jin L Craven RJ Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1 J Biol Chem 2012 287 14494 14501 10.1074/jbc.M111.324921 22418433 

  34. 34. Li CL Yang D Cao X Wang F Hong DY Wang J Shen XC Chen Y Fibronectin induces epithelial–mesenchymal transition in human breast cancer MCF-7 cells via activation of calpain Oncol Lett 2017 13 3889 3895 10.3892/ol.2017.5896 28521486 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로